Abstract
The effect of 18 months' inhibition of angiotensin-converting enzyme by captopril on the leakage of fluorescein through the blood-retina barrier was examined in a prospective, randomized control study of 20 normotensive insulin-dependent diabetic patients with nephropathy and background retinopathy. After 18 months, 15 patients remained in the study. Fluorescein leakage remained nearly unchanged in the captopril-treated group, being 4.1 ± 4.1 (mean ± SD) × 10−7 cm/s at baseline and 4.2±4.1 × 10−7 cm/s after 18 months' treatment. The permeability increased significantly (P<0.01) from 3.3±2.2 × 10−7 cm/s to 5.6±3.5 × 10−7 cm/s at 18 months in the control group. Arterial blood pressure was nearly constant in both groups throughout the study. The results indicate that angiotensin-converting enzyme inhibition with captopril can arrest or delay a progressive breakdown of the blood-retina barrier in normotensive insulin-dependent diabetic patients with nephropathy and background retinopathy.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Anderson S, Rennke HG, Garcia DL, Brenner BM, Riley SL, Sandstrom DJ (1989) Short and long term effects of antihypertensive therapy in the diabetic rat. Kidney Int 36:526–536
Cunha-Vaz JG, Abreu JR, Campos AJ, Figo GM (1975) Early breakdown of the blood-retinal barrier in diabetes. Br J Ophthalmol 59:649–656
Dalgaard P, Barker VA, Lund-Andersen H (1989) Vitreous fluorophotometry: mathematical analysis of the effect of peripheral leakage on axial scans. Invest Ophthalmol Vis Sci 30:1522–1526
Fernandez LA, Twickler J, Mead A (1985) Neovascularization produced by angiotensin II. J Lab Clin Med 105:141–145
Hommel E, Parving H-H, Mathiesen E, Edsberg B, Damkjær Nielsen M, Giese J (1986) Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy. Br Med J 293:467–470
Hostetter TH, Troy JL, Brenner BM (1981) Glomerular hemodynamics in experimental diabetes. Kidney Int 19:410–415
Igic R, Kojovic V (1980) Angiotensin I converting enzyme (kinase II) in ocular tissues. Exp Eye Res 30:299–303
Jensen PK, Steven K, Blæhr H, Christiansen JS, Parving H-H (1986) Effects of indomethacin on glomerular hemodynamics in experimental diabetes. Kidney Int 29:490–495
Knowler WC, Bennett PA, Ballantine EJ (1980) Increased incidence of retinopathy in diabetics with elevated blood pressure. N Engl J Med 302:645–650
Kohner EM, McLeod D, Marshall J (1982) Diabetic eye disease. In: Keen H, Jarrett J (eds) Complications of diabetes. Arnold, London, pp 19–108
Korthuis RJ, Pitts VH, Granger DN (1987) Intestinal capillary filtration in experimental diabetes mellitus. Am J Physiol 253:G20-G25
Krogsaa B, Lund-Andersen H, Mehlsen J, Sestoft L, Larsen J (1981) The blood-retinal barrier permeability in diabetic patients. Acta Ophthalmol 59:689–694
Krogsaa B, Lund-Andersen H, Parving H-H, Bjældager P (1983) The blood-retinal barrier permeability in essential hypertension. Acta Ophthalmol 61:541–544
Krogsaa B, Lund-Andersen H, Mehlsen J, Sestoft L (1987) Blood-retinal barrier permeability versus diabetes duration and retinal morphology in insulin-dependent diabetic patients. Acta Ophthalmol 65:686–692
Larsen M, Dalgaard P, Lund-Andersen H (1987) Differential spectrofluorophotometry in the human vitreous body. Noninvasive assessment of the visual system, technical digest. Optical Society of America, Washington, DC, pp 144–147
Larsen M, Loft S, Hommel E, Lund-Andersen H (1988) Fluorescein and fluorescein glucuronide in plasma after intravenous injection of fluorescein. Acta Ophthalmol 66:427–432
Lund-Andersen H, Krogsaa B, Jensen PK (1982) Fluorescein in human plasma in vivo. Acta Ophthalmol 60:709–716
Lund-Andersen H, Krogsaa B, LaCour M, Larsen J (1985) Quantitative vitreous fluorophotometry applying a mathematical model of the eye. Invest Ophthalmol Vis Sci 26:698–710
Lund-Andersen H, Larsen M, Dalgaard P, Olsen W (1987) Fluorescein and fluorescein glucuronide in the vitreous body of diabetic patients. Graefe's Arch Clin Exp Ophthalmol 225:173–176
Marre M, Chatellier G, Leblanc H, Guyenne T-T, Ménard J, Passa P (1988) Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria. Br Med J 297:1092–1095
Mogensen CE (1982) Long term antihypertensive treatment inhibiting progression of diabetic nephropathy. Br Med J 285:685–688
Mortensen HB (1980) Quantitative determination of haemoglobin A1c by thin layer isoelectric focusing. J Chromatogr 182:325–333
Olesen S-P (1989) An electrophysiological study of microvascular permeability and its modulation by chemical mediators. Acta Physiol Scand [Suppl] 136:[Suppl] 579
Parving H-H, Hommel E (1989) Prognosis in diabetic nephropathy. Br Med J 299:230–233
Parving H-H, Andersen AR, Smidt UM, Svendsen PA (1983) Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Lancet 1:1175–1179
Parving H-H, Andersen AR, Smidt UM, Hommel E, Mathiesen ER, Svendsen PA (1987) Effect of antihypertensive treatment on kidney function in diabetic nephropathy. Br Med J 294:1443–1447
Parving H-H, Hommel E, Smidt UM (1988) Protection of kidney function and decrease in albuminuria by captopril in insulin-dependent diabetics with nephropathy. Br Med J 297:1086–1091
Parving H-H, Hommel E, Nielsen MD, Giese J (1989) Effect of captopril on blood pressure and kidney function in normotensive insulin-dependent diabetics with nephropathy. Br Med J 299:533–536
Parving H-H, Larsen M, Hommel E, Lund-Andersen H (1989) Effect of antihypertensive treatment on blood-retinal barrier permeability to fluorescein in hypertensive type 1 (insulin-dependent) diabetic patients with background retinopathy. Diabetologia 32:440–444
Sinclair SH, Grunwald JE, Riva C, Braunstein SL, Nichols CW, Schwartz S (1982) Retinal vascular autoregulation in diabetes mellitus. Ophthalmology 89:748–750
Sramek SJ, Wallow IHL, Day RP, Ehrlich EN (1988) Ocular renin-angiotensin: immunohistochemical evidence for the presence of prorenin in eye tissue. Invest Ophthalmol Vis Sci 29:1749–1752
West KM, Erdreich LJ, Stober JA (1980) A detailed study of risk factors for retinopathy and nephropathy in diabetes. Diabetes 29:501–508
Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner BM (1986) Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 77:1925–1930
Zeimer RC, Noth JM (1984) A new method of measuring in vivo the lens transmittance, and study of lens scatter, fluorescence and transmittance. Ophthalmic Res 16:246–255
Author information
Authors and Affiliations
Additional information
The authors have no commercial or proprietory interest in the drugs or instruments used in this study
Rights and permissions
About this article
Cite this article
Larse, M., Hommel, E., Parving, HH. et al. Protective effect of captopril on the blood-retina barrier in normotensive insulin-dependent diabetic patients with nephropathy and background retinopathy. Graefe's Arch Clin Exp Ophthalmol 228, 505–509 (1990). https://doi.org/10.1007/BF00918480
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00918480